Axon Enterprise, Inc. logo AXON - Axon Enterprise, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 17
HOLD 4
SELL 0
STRONG
SELL
0
| PRICE TARGET: $702.22 DETAILS
HIGH: $820.00
LOW: $440.00
MEDIAN: $732.00
CONSENSUS: $702.22
UPSIDE: 17.51%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Platform & Compounding FCF 85% confidence

Primary model: Two-stage FCF DCF

Valuation Signal Overvalued Strong
Trading 107.8% above fair value
Current Price $597.59
Bear Case $161.19 73.0% downside ($161.19 - $597.59) / $597.59 = -73.0% 12% stage 1 growth, 12% discount
Fair Value $287.53 51.9% downside ($287.53 - $597.59) / $597.59 = -51.9% 19% stage 1 growth, 12% discount
Bull Case $443.33 25.8% downside ($443.33 - $597.59) / $597.59 = -25.8% 25% stage 1 growth, 12% discount

Adjust Assumptions

19.5%
12.0%
3.0%

Key Value Driver

FCF growth rate (19% base case)

Terminal Value % of EV 42%
Implied Market Multiple 78.1x
Market is pricing in (growth) 29.4% vs our 19.5% base

Plain-Language Summary

Using a two-stage FCF DCF with 19% growth decelerating over 15 years, discounted at 12%, the base-case intrinsic value is $287.53 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (21 analysts) $702.22
Analyst Range $440.00 – $820.00
Divergence from AlphaVal 59%

Warnings

Stock-based employee pay equals 508% of profits. This dilutes existing shareholders, so cash flow alone overstates what owners really earn.
Wall Street's average price target is $702.22 (from 21 analysts). Our estimate is 59% below the consensus -- consider that gap carefully.

Key Risks

  • P/E alone misleads — earnings depressed by growth investment
  • Cyclical or commodity businesses may be misclassified as platforms
  • Terminal value dominance suggests sensitivity to long-run assumptions